ÇѸ²´ëÇб³¼º½Éº´¿ø

¸¶È¿ÀÏ ±³¼ö

hima@hallym.or.kr
  • Àü¹®¼¾ÅÍ ³ú½Å°æ¼¾ÅÍ
  • Áø·á°ú ½Å°æ°ú

Àü¹®Áø·áºÐ¾ß

ÀÌ»ó¿îµ¿Áúȯ, ¶³¸²Áõ, ÆÄŲ½¼º´, ¼ö¸éÁúȯ, ³úÀüÁõ, º¸Å彺ġ·á

ÀüÈ­ ¿¹¾à 1577-1801
±³¼ö´Ô»çÁø

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2025-12-08 ~ 2025-12-13)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¼¾ÅÍÁø·á¼¾ÅÍÁø·á
¿ÀÈÄ ¼¾ÅÍÁø·á¼¾ÅÍÁø·á
±³¼ö´Ô »çÁø

±âº»Á¤º¸

ÇзÂ

ÇзÂ

1997.03 ~ 2003.02¿ï»ê´ëÇб³ ´ëÇпø ¹Ú»ç

1993.03 ~ 1995.02¿ï»ê´ëÇб³ ´ëÇпø ¼®»ç

1983.03 ~ 1991.02¼­¿ï´ëÇб³ Àǰú´ëÇÐ Çлç

°æ·Â

°æ·Â

2011.03 ~ ÇѸ²´ëÇб³¼º½Éº´¿ø ½Å°æ°ú ±³¼ö

2006 ~ 2007Neurological Institute of Columbia University in NY Presbyterian Hospital ¿¬¼ö(06~07) (Movement Disorders)

1996 ~ 1998¼­¿ï¾Æ»êº´¿ø ½Å°æ°ú ÀüÀÓÀÇ (ÀÓ»ó½Å°æ»ý¸®-¼ö¸é, °£Áú, ±ÙÀüµµ)

1992 ~ 1996¼­¿ï¾Æ»êº´¿ø ½Å°æ°ú Àü°øÀÇ

1991 ~ 1992¼­¿ï¾Æ»êº´¿ø ÀÎÅÏ

ÇÐȸȰµ¿

ÇÐȸȰµ¿

ÀÓ»ó½Å°æ»ý¸®ÇÐȸ ºÎȸÀå

´ëÇѳëÀνŰæÀÇÇÐȸ Ãѹ«ÀÌ»ç

´ëÇÑÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿ÁúȯÇÐȸ ºÎȸÀå

´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿ÁúȯÇÐȸ Á¤È¸¿ø

Movement Disorders Society Á¤È¸¿ø

´ëÇѰ£ÁúÇÐȸ Á¤È¸¿ø

´ëÇѽŰæ°úÇÐȸ Á¤È¸¿ø

³í¹®

Pathological role of immunoproteasome PSMB8 in Parkinson's disease: a link between ¥á-synuclein aggregation and immune activation (Ebiomedicine)

Differential Peripheral NLRP3 Inflammasome Expression in Parkinson's Disease and Multiple System Atrophy / ^^¿µ¹® Á¦¸ñÀ» ¹Ýµå½Ã ±âÀçÇϽñ⠹ٶø´Ï´Ù. (Journal of Movement Disorders)

Peripheral inflammatory markers and clinical phenotypes reflecting the impact of diabetes on Parkinson's disease / ^^¿µ¹® Á¦¸ñÀ» ¹Ýµå½Ã ±âÀçÇϽñ⠹ٶø´Ï´Ù. (Journal of Parkinson's Disease)

Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies (vol 271, pg 6729, 2024) (JOURNAL OF NEUROLOGY)

Prevalence and clinical impact of alpha-synuclein pathology in idiopathic normal pressure hydrocephalus: Insights from RT-QuIC assay (PARKINSONISM & RELATED DISORDERS)

Sex-specific Characteristics of Parkinson¡¯s Disease: Characteristics at Diagnosis and Complications in the Disease Course (¾à ÇРȸ Áö)

Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson¡¯s disease mouse model (npj Parkinson's Disease)

Monocyte to high-density lipoprotein cholesterol ratio reflects the peripheral inflammatory state in parkinsonian disorders (PARKINSONISM & RELATED DISORDERS)

Urodynamic study and its correlation with cardiac meta-iodobenzylguanidine (MIBG) in body-first and brain-first subtypes of Parkinson's disease (European Journal of Neurology)

Olfactory and Gustatory Function in Early-Stage Parkinson¡¯s Disease: Implications for Cognitive Association (Journal of Movement Disorders)
½Å°æÇÐ (¹ü¹®¿¡µàÄÉÀ̼Ç)

(Harrison's) ³»°úÇÐ. / ÇØ¸®½¼ ³»°úÇÐ (MIP)

½Å°æÇÐ / Neurology (±ºÀÚÃâÆÇ»ç)